Phase 2 Study - Erdosteine in Patients With CB/COPD
NCT00338507
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Bronchitis
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Erdosteine
Sponsor
Adams Respiratory Therapeutics